News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Heather Moore, CPP, PharmD

Heather Moore, CPP, PharmD

Heather Moore, CPP, PharmD, is a clinical pharmacist practitioner at the Duke Cancer Center Breast Clinic.

Articles by Heather Moore, CPP, PharmD

Neil Iyengar, MD, associate professor, Department of Hematology and Medical Oncology, co-director, Breast Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine, director, Survivorship Services, Winship Cancer Institute of Emory University; Heather Moore, CPP, PharmD, clinical pharmacist practitioner, Duke Cancer Center Breast Clinic; Sarah Donahue, MPH, NP, nurse practitioner, University of California San Francisco Health

Multidisciplinary Breast Cancer Experts Outline Proactive Strategies for Managing Treatment-Related Toxicities: With Neil Iyengar, MD; Heather Moore, CPP, PharmD; and Sarah Donahue, MPH, NP

ByDr. Neil Iyengar, MD,Heather Moore, CPP, PharmD,Sarah Donahue, MPH, NP, AOCNP

January 29th 2026

Breast cancer experts discuss adverse effect management when using breast cancer therapies targeting the PI3K, AKT, and mTOR pathways.

Latest Updated Articles

Trending on OncLive

Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression

FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma

Oncology Fellows Presents a New Drug Cheat Sheet for Fellows